Zarogoulidis, P.; Petridis, D.; Kosmidis, C.; Sapalidis, K.; Nena, L.; Matthaios, D.; Papadopoulos, V.; Perdikouri, E.I.; Porpodis, K.; Kakavelas, P.;
et al. Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival. Diseases 2023, 11, 26.
https://doi.org/10.3390/diseases11010026
AMA Style
Zarogoulidis P, Petridis D, Kosmidis C, Sapalidis K, Nena L, Matthaios D, Papadopoulos V, Perdikouri EI, Porpodis K, Kakavelas P,
et al. Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival. Diseases. 2023; 11(1):26.
https://doi.org/10.3390/diseases11010026
Chicago/Turabian Style
Zarogoulidis, Paul, Dimitrios Petridis, Christoforos Kosmidis, Konstantinos Sapalidis, Lila Nena, Dimitris Matthaios, Vasilis Papadopoulos, Eleni Isidora Perdikouri, Konstantinos Porpodis, Paschalis Kakavelas,
and et al. 2023. "Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival" Diseases 11, no. 1: 26.
https://doi.org/10.3390/diseases11010026
APA Style
Zarogoulidis, P., Petridis, D., Kosmidis, C., Sapalidis, K., Nena, L., Matthaios, D., Papadopoulos, V., Perdikouri, E. I., Porpodis, K., Kakavelas, P., & Steiropoulos, P.
(2023). Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival. Diseases, 11(1), 26.
https://doi.org/10.3390/diseases11010026
